已收盘 12-19 16:00:00 美东时间
-0.030
-1.38%
The gross proceeds from the offering are expected to be approximately $3.5 million, prior to deducting placement agent's fees and other offering expenses payable by the Company. The Company intends to use
2024-09-17 15:07
Shares of Exicure, Inc. (NASDAQ:XCUR) rose sharply in today's pre-market tradin...
2024-09-16 18:07
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Jefferies raised the price target for BrightView Holdings, Inc. (NYSE:BV) from $13 to $17. Jefferies analyst S...
2024-08-21 20:58
Maxim Group analyst Anthony Vendetti maintains Dermata Therapeutics (NASDAQ:DRMA) with a Buy and lowers the price target from $10 to $6.
2024-08-21 20:21